That's for sharing....I think it gives a nice prespective...

That's for sharing....I think it gives a nice prespective of things involved and why it takes over than what ppl expect....

Saying that, question is what is an ideal time frame gap between release of results from P2 to getting P3 ethics approval as a start... I know every drug is different so there is no definite answer...

Also, can anyone reminds me to next steps for DKD? I understand that they are working on what should be next steps for DKD given the sub analysis... As much as I think P3 announcement as a next step would sky rocket the SP, I think we will do another P2 study on patient group based on the results ... anyone with a different view and why? I hope that another P2 will be done via a partnership and not us...

Finally, hope that they have plan B for funding (non dilutive) in case of unsuccessful Covid trials... not saying that will happen but hope we are not putting all eggs in one basket for future planning....